8-KRegulation FDOther EventsExhibits & Filings

QUEST DIAGNOSTICS INC 8-K Report, Regulation FD Disclosure (May 18, 2016)

Filed May 18, 2016For Securities:DGX

Summary

Quest Diagnostics Incorporated (DGX) filed an 8-K on May 18, 2016, primarily to disclose an updated outlook for the full year 2016 and announce the completion of the sale of its Focus Diagnostics products business. This sale and the associated proceeds are expected to be utilized for share repurchases, aligning with the company's capital deployment strategy. Investors should note that this filing provides forward-looking information and details on the use of funds from a divested segment. The company's updated 2016 outlook, while not detailed in the provided excerpt, is a crucial piece of information for investors assessing future performance and profitability. The strategic decision to sell the Focus Diagnostics business and redeploy capital through share buybacks signals a focus on optimizing the company's portfolio and returning value to shareholders.

Key Highlights

  • 1Quest Diagnostics completed the sale of its Focus Diagnostics products business.
  • 2The company issued an updated outlook for the full year 2016.
  • 3Proceeds from the sale will be used to repurchase common stock.
  • 4The share repurchase program is consistent with the company's disciplined capital deployment strategy.
  • 5Approximately $2 billion in stock has been repurchased since 2012.
  • 6The filing incorporates a press release dated May 18, 2016, as an exhibit.

Frequently Asked Questions

The main purpose of this 8-K filing was to announce the completion of the sale of Quest Diagnostics' Focus Diagnostics products business and to provide an updated outlook for the full year 2016.

Quest Diagnostics plans to use the proceeds from the sale of the Focus Diagnostics products business to repurchase its common stock.

The share repurchase plan is significant as it demonstrates the company's commitment to returning capital to shareholders and is consistent with its strategy of disciplined capital deployment. This action, combined with past repurchases, brings the total since 2012 to approximately $2 billion.

More details about the updated 2016 outlook would be found in the press release dated May 18, 2016, which is attached as Exhibit 99.1 to this 8-K filing.